Click for full image >>
is a biopharmaceutical company focused on the development of
novel treatments for B-cell malignancies and autoimmune diseases.
TG Therapeutics, Inc. Announces Second Quarter 2015 Financial Results and Business Update
TG Therapeutics, Inc. to Host Conference Call on Second Quarter 2015 Financial Results and Business Update
3 Columbus Circle, 15th Floor, New York, NY 10019 - P:212.554.4484 - Email Us
Web Site Development by Tidal Media Group